Skip to main content
Premium Trial:

Request an Annual Quote

Geisinger to Use Ardais Biospecimen Management System

NEW YORK, July 6 (GenomeWeb News) - Pennsylvania-based health care provider Geisinger Health System will use the Ardais System biospecimen-management system in its cancer research programs, Ardais said today.


Geisinger will use the Ardais platform to collect, manage, and distribute clinically annotated biospecimens as part of a new research collaboration with the Windber Research Institute in which Geisinger will integrate its tissue-banking initiatives with Windber's molecular analytical capabilities.


The Ardais System will serve as the "backbone" of a clinically annotated biospecimen collection network for the collaboration, the company said.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.